In a significant milestone for Australia’s vaccine rollout, last week we surpassed
11 million vaccine doses administered across the country. This included the last million doses delivered in only 7 days.
Last week had the highest daily increase in doses administered on 22 July, at 196,430 recorded doses-over 10,000 more than the previous record (that was also in the last week). There was also a new record day for doses in primary care on 20 July, breaking the 100,000 mark. This takes primary care vaccinations past 5 million doses. It also reflects the participation now of around1500 General Practices in administering Pfizer, with more to join this month.
State and territory clinics have now administered more than 4.9 million doses of a COVID-19 vaccine.
Close to 8 million people in Australia have now received first dose protection. This includes over 77 percent of people aged 70 and over, over 70 per cent of people aged 60 and over and over 62 percent of people aged 50 and over.
The rollout continues to accelerate this week, as our supply of Pfizer triples to one million doses per week.
We continue to support the delivery of vaccinations in NSW, where they are currently managing an outbreak response. Throughout week 22, we’ve administered more than 400,000 doses in NSW.
Victoria has also experienced an increase of approximately 9 per cent in week 22 compared to week 21.
Supplying and producing the vaccine
The ability to manufacture vaccines onshore has been essential to the progress of our rollout and CSL has now manufactured and supplied over 12.3million doses of vaccine for use in Australia.
Last week, around 1 million doses of Pfizer were released for distribution.
Over the coming week, the Therapeutic Goods Administration will conduct sample testing of over 1 million doses of Pfizer vaccine, along with over 1.6 million doses of AstraZeneca vaccine produced onshore by CSL, prior to releasing the vaccines for distribution.
Distributing the vaccine
With support from our Distribution Partners DHL and Linfox, more than 1.2 million vaccine doses were delivered across Australia to metropolitan, rural and remote locations, along with 2683 deliveries of consumables.
- Ordering and Delivery. 99.9 per cent of vaccine orders were completed last week with one order to be finalised today.
- Australia’s assistance to the Pacific. This week another 120,000 doses were made available for distribution to the Pacific.
We expect more than 1.4 million vaccine doses to be delivered across Australia in the coming week.
Administering the vaccine
This week, more than 1.08 million doses were administered across the country, taking the total number of doses administered over 11.2 million. It took 47 days to reach our first million doses of vaccine administered and 7 days for the most recent.
- Total sites. This week we have 5,145 General Practices, 136 Commonwealth Vaccination Centres (CVC), 251 Pharmacies and 158 Aboriginal Community Controlled Health Services (ACCHS) delivering vaccines, along with 879 state and territory sites, taking the total number of vaccination sites across the country to over 6,500. Approximately 150 general practices will join the roll-out in coming weeks.
- Primary Care transition to Pfizer. This week have almost 1500 General Practices, 120 CVC and over 112 ACCHS administering Pfizer, along with the State and Territory clinics. A further 280 GPs have been invited to commence vaccinating with Pfizer during August.
- Aged Care. With our vaccine workforce service providers, we continue to focus on those most at risk in our residential aged care facilities, and have completed first and second dose visits to all 2,566. We have completed first and second dose roving clinics to 145 residential aged care facilities in Victoria and are continuing to conduct roving clinics in 299 residential aged care facilities across 23 Local Government Areas in New South Wales. These roving clinics have a focus on vaccinating any residents yet to receive a first or second dose and the aged care workforce.
- Disability. We continue to ramp up our visits to disability residents with complex needs who require in-reach services. More than 15,800 people with a disability in a residential setting have now received at least one dose of vaccine, with additional vaccine workforce providers on board to accelerate the rollout in the coming weeks. In-reach will also need to be provided to identified residents in Phase 1b (those that live alone that cannot access a vaccination in the community).